Wellspring is focused on the discovery and development of small molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases.
Troy Wilson, Ph.D., J.D.
Executive Chairman
Yi Liu, Ph.D.
Chief Scientific Officer
Pingda Ren, Ph.D.
Senior Vice President, Chemistry
Annette North, Esq.
General Counsel